343
Participants
Start Date
July 16, 2018
Primary Completion Date
October 3, 2019
Study Completion Date
February 21, 2020
SAR440340
Pharmaceutical form: Solution for injection; Route of administration: SC
Placebo
Pharmaceutical form: Solution for injection; Route of administration: SC
Any Inhaled Corticosteroids as prescribed by treating physician as standard of care
Pharmaceutical form: Aerosol or Dry Powder inhaler Route of administration: Inhaled
Any Long Acting Beta Agonist as prescribed by treating physician as standard of care
Pharmaceutical form: Aerosol or Dry Powder inhaler; Route of administration: Inhaled
Any Long Acting Muscarinic Agonist as prescribed by treating physician as standard of care
Pharmaceutical form: Aerosol or Dry Powder inhaler; Route of administration: Inhaled
Any short-acting β agonist as prescribed by treating physician as standard of care
Pharmaceutical form: Aerosol or Dry Powder inhaler; Route of administration: inhaled
Investigational Site Number 0320003, Rosario
Investigational Site Number 0360004, Clayton
Investigational Site Number 0360003, Frankston
Investigational Site Number 0360002, Chermside
Investigational Site Number 0360005, Bedford Park
Investigational Site Number 0360006, Kent Town
Investigational Site Number 0360001, Murdoch
Investigational Site Number 2760006, Berlin
Investigational Site Number 2760005, Rüdersdorf Bei Berlin
Investigational Site Number 8400009, Philadelphia
Investigational Site Number 2760002, Hamburg
Investigational Site Number 8040005, Vinnytsia
Investigational Site Number 8400012, Columbia
Investigational Site Number 2760001, Großhansdorf
Investigational Site Number 8400019, Chapel Hill
Investigational Site Number 8400004, Raleigh
Investigational Site Number 8400013, Jacksonville
Investigational Site Number 7920002, Mersin
Investigational Site Number 7920001, Istanbul
Investigational Site Number 7920006, Izmir
Investigational Site Number 7920007, Izmir
Investigational Site Number 8040003, Ternopil
Investigational Site Number 8400008, Greenfield
Investigational Site Number 8400011, Minneapolis
Investigational Site Number 2760007, Koblenz
Investigational Site Number 8040008, Chernivtsi
Investigational Site Number 8040002, Kharkiv
Investigational Site Number 8040011, Kharkiv
Investigational Site Number 8040006, Odesa
Investigational Site Number 7920008, Kırıkkale
Investigational Site Number 8400007, Plano
Investigational Site Number 8040012, Ivano-Frankivsk
Investigational Site Number 8040004, Ivano-Frankivsk
Investigational Site Number 2760004, München
Investigational Site Number 8400002, Los Angeles
Investigational Site Number 8400006, Rolling Hills Estates
Investigational Site Number 8400003, Riverside
Investigational Site Number 8400015, Westminster
Investigational Site Number 8400001, Medford
Investigational Site Number 6430003, Moscow
Investigational Site Number 6430001, Moscow
Investigational Site Number 6430005, Moscow
Investigational Site Number 6430002, Moscow
Investigational Site Number 6430007, Saint Petersburg
Investigational Site Number 6430010, Saint Petersburg
Investigational Site Number 6430006, Saint Petersburg
Investigational Site Number 6430009, Stavropol
Investigational Site Number 6430004, Ulyanovsk
Investigational Site Number 1520002, Quillota
Investigational Site Number 1520001, Santiago
Investigational Site Number 1520007, Santiago
Investigational Site Number 1520004, Santiago
Investigational Site Number 8400016, North Dartmouth
Investigational Site Number 8400020, South Dartmouth
Investigational Site Number 8400005, Jamaica
Investigational Site Number 0320001, Buenos Aires
Investigational Site Number 0320005, Caba
Investigational Site Number 0320002, Caba
Investigational Site Number 0320004, Caba
Investigational Site Number 0320006, Quilmes
Investigational Site Number 1240002, Burlington
Investigational Site Number 1240009, Hamilton
Investigational Site Number 1240003, Montreal
Investigational Site Number 1240001, Montreal
Investigational Site Number 1240005, Québec
Investigational Site Number 1240006, Saint-Charles-Borromée
Investigational Site Number 1240008, Trois-Rivières
Investigational Site Number 1240007, Vancouver
Investigational Site Number 1240004, Victoriaville
Investigational Site Number 1520005, Talca
Investigational Site Number 1520003, Talcahuano
Investigational Site Number 6160001, Bialystok
Investigational Site Number 6160008, Bialystok
Investigational Site Number 6160005, Bydgoszcz
Investigational Site Number 6160009, Grudziądz
Investigational Site Number 6160007, Krakow
Investigational Site Number 6160002, Poznan
Investigational Site Number 6160006, Poznan
Investigational Site Number 6160010, Rzeszów
Investigational Site Number 6160003, Żnin
Investigational Site Number 7920004, Ankara
Investigational Site Number 8040007, Kyiv
Investigational Site Number 8040001, Kyiv
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Sanofi
INDUSTRY